ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.27
-0.10 (-1.19%)
At close: Jul 24, 2026, 4:00 PM EDT
8.22
-0.05 (-0.58%)
After-hours: Jul 24, 2026, 7:46 PM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $1.92 billion as of July 24, 2026. Its market cap has decreased by -53.32% in one year.
Market Cap
1.92B
Enterprise Value
1.98B
1-Year Change
-53.32%
Ranking
Category
Stock Price
$8.27
ChartMarket Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $1.92B, an increase of 3,718.25%. That is a compound annual growth rate of 32.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.92B | -55.85% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.98B |
| Aurinia Pharmaceuticals | 1.97B |
| Rapport Therapeutics | 1.95B |
| Precigen | 1.93B |
| Monte Rosa Therapeutics | 1.92B |
| Zenas BioPharma | 1.92B |
| GH Research | 1.87B |
| Ocular Therapeutix | 1.86B |